Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
TSXV - Free Realtime Quote CAD

PharmaCorp Rx Inc. (PCRX.V)

Compare
0.5600
0.0000
(0.00%)
As of February 24 at 1:50:51 PM EST. Market Open.
Loading Chart for PCRX.V
DELL
  • Previous Close 0.5600
  • Open 0.5500
  • Bid 0.5500 x --
  • Ask 0.6000 x --
  • Day's Range 0.5500 - 0.5600
  • 52 Week Range 0.2100 - 0.8750
  • Volume 191
  • Avg. Volume 35,798
  • Market Cap (intraday) 64.749M
  • Beta (5Y Monthly) -5.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; vitamins and supplements; and convenience and confectionary products. The company was incorporated in 2021 and is based in Saskatoon, Canada.

www.pharmacorprx.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PCRX.V

View More

Performance Overview: PCRX.V

Trailing total returns as of 2/25/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

PCRX.V
3.70%
S&P/TSX Composite index
2.35%

1-Year Return

PCRX.V
166.67%
S&P/TSX Composite index
17.68%

3-Year Return

PCRX.V
366.67%
S&P/TSX Composite index
21.37%

5-Year Return

PCRX.V
366.67%
S&P/TSX Composite index
43.48%

Compare To: PCRX.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PCRX.V

View More

Valuation Measures

As of 2/24/2025
  • Market Cap

    64.75M

  • Enterprise Value

    39.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    25.04

  • Price/Book (mrq)

    2.17

  • Enterprise Value/Revenue

    27.98

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -142.45%

  • Return on Assets (ttm)

    -7.91%

  • Return on Equity (ttm)

    -12.23%

  • Revenue (ttm)

    1.4M

  • Net Income Avi to Common (ttm)

    -1.99M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.68M

  • Total Debt/Equity (mrq)

    3.29%

  • Levered Free Cash Flow (ttm)

    -722.07k

Research Analysis: PCRX.V

View More

People Also Watch